Yokohama City University succeeded in detecting antiviral antiviral antibodies contained in the patient serum of COVID-19.

Yokohama City University and Yokohama City University, a public university corporation (President Yoshiyuki Futami). (Installer: Yokohama City) is promoting a wide range of collaborations, including the development of human resources, providing medical care, and solving urban issues and issues closely related to civil life.
We are pleased to announce that a research team at Yokohama City University has succeeded in detecting viral antibodies that lead to a new diagnostic method as the number of patients with COVID-19 infection increases.
The method used to detect virus antibodies is an epoch-making process that can be determined in a short time without using a special device, and the risk of secondary infection is low.
In the future, we will verify with a large number of samples and aim for practical use, such as establishing diagnostic methods and developing diagnostic kits, but it is expected to have a significant effect on simplifying and speeding up the diagnosis of COVID-19 infection.